every episode ofbacteremia recorded at the Bacteriology Laboratory was registered for the purposes of this study. The medical records of 373 patients for whom a blood culture was positive for S. aureus were retrospectively reviewed. Seventeen patients with polymicrobial bacteremia were excluded. In addition, single positive hemocultures for 57 patients for whom no further culture yielded the same phage type were judged as contaminated (see below). Eight of these patients had a subsequent episode of bacteremia due to another pathogen, 21 patients had postoperative fever with spontaneous resolution, and in 28 cases the clinical course did not suggest infection. Records for 18 patients were not available for the study. The remaining 281 medical charts were analyzed for data regarding primary and secondary foci, clinical signs and symptoms, laboratory findings, the treating physician's opinion in regard to the severity of the infection, antibiotic treatment, complications, follow-up, phage type, and in vitro susceptibility of S. aureus. If the presence or absence of a particular finding was not clearly indicated on a chart, the case was excluded from analysis in regard to that finding, a practice that resulted in the use of variable denominators in the data we present herein.
Contamination. The positivity of a single blood culture per set (one aerobic and one anaerobic bottle) was considered indicative of contamination, unless an identical strain of S. aureus was additionally cultivated from a specimen from a focus in a patient who had appropriate clinical signs [13, 14] .
Episode. An episode ofbacteremia was defined when the results of the cultures were nositive or when reurllt nof a fir-ther hemoculture were positive later than 1 week after negative results were obtained [15] . Acquisition. Bacteremia was judged to be community acquired (CA) when the positive culture results were obtained at or within 48 hours after admission or when there was evidence of S. aureus infection on admission [ 10, [16] [17] [18] . Bacteremia was judged to be hospital acquired (HA) when the positive culture results were obtained >48 hours after hospitalization. Episodes of bacteremia secondary to infections of dialysis access sites were considered to be due to HA organisms.
Underlying conditions. Glucocorticosteroid therapy was considered a risk factor if a patient had received the daily equivalent of >25 mg ofprednisone for at least 1 week prior to the time the positive blood culture results were obtained [19] . Chronic renal failure was defined as a persistent rise in serum creatinine levels to > 180 ,tmol/L [20] . Diabetes mellitus was a risk factor in cases of insulin dependency or chronic treatment with oral hypoglycemic agents [20] . Previous hospitalization within 30 days of onset of illness was viewed as predisposing the patient to septicemia [21] . Other conditions frequently cited as predisposing factors to infection (table 1) Clinical significance. Criteria for clinical significance were used as proposed by Michel et al. [17] . These criteria were the existence of true bacteremia plus at least three of the following factors: leukocyte count, >10 X 109/L; temperature, >38.5?C; heart rate, >100/min; chills; hypotension (systolic blood pressure, <90 mm Hg or a fall of >30 mm Hg); or new oliguria (urine output, <400 mL/24 hours).
Complicated bacteremia. Bacteremia was considered to be complicated if a focus of infection was absent or nonremovable [32, 33] .
Primary and secondary bacteremia. Bacteremia occurring in the absence of an apparent portal of entry was classified as primary. If a portal of entry was identified, bacteremia was defined as secondary.
Portal ofentryand secondaryfoci. The initial staphylococcal lesion leading to bacteremia was defined as the portal of entry. Other foci were considered as sequelae resulting from seeding of the initial lesion. Primary infection of the respiratory and urinary tracts was diagnosed only when symptoms and signs typically associated with bacterial infections of those systems were present and coincident with appropriate results of culture. The presence of Staphylococcus isolates in urine was considered to be secondary to bacteremia if the phage type of organisms isolated from urine and blood matched. An intravascular catheter was considered as the portal of entry if (1) there was evidence of inflammation at the catheter insertion site and/or (2) a catheter-tip culture was positive for S. aureus and (3) there was no evidence of a source of infection elsewhere [34] . Endocarditis was defined according to Nolan 
Results
During the 7-year period investigated, 2,746 episodes of bacteremia were diagnosed in the laboratory. The most frequent isolates were Escherichia coli (22.8%), Streptococcus species (16.2%), and coagulase-negative staphylococcus (13.2%). S. aureus was isolated in 373 cases (13.6%). All cases of staphylococcal bacteremia were observed in either the surgical or the medical wards, with the exception of 14 cases that were observed in departments dealing with the following specialties: gynecology and obstetrics (4); dermatology (5); ear, nose, and throat disorders (2); paraplegic patients ( (42%) were female. CA bacteremia occurred more frequently in females (33%) than in males (25%).
Underlying conditions. Table 1 shows the underlying conditions that were present in 268 subjects (95%). They were found in 98% of patients with HA bacteremia and 87% of patients with CA bacteremia. Many patients had more than one underlying condition. There were only four patients with a history of intravenous drug abuse. No patient was infected with the human immunodeficiency virus. For patients with HA bacteremia, predisposing factors more often were intravenous catheters, surgical wounds, previous hospitalization, alcohol abuse, therapy with corticosteroids, and trauma. Of the 200 patients with HA bacteremia, 160 (80%) had an intravascular device; this device was proved bacteriologically and/or clinically to be the portal of entry for S. aureus for 38.5% of these patients (table 2) .
Clinical signs and symptoms and laboratoryfindings. At the time their first positive blood culture results were obtained, 91% of the patients had fever and the general condition of 85% was impaired. Thirty-eight percent presented with clouding of consciousness, and one-quarter suffered from chills. Vomiting, nausea, myalgia, and dyspnea were reported in 13%-14%. Shock (9%), hemiplegia (6%), stiff neck (4%), diarrhea (2.5%), headache (1.5%), and seizures (1%) were less frequent. Only 1% showed no clinical abnormalities at the time the hemoculture was performed.
Primary vs. secondary bacteremia. In 219 patients (78%) an apparent primary site of S. aureus infection was identified.
Among patients with HA bacteremia the detection of a portal of entry (i.e., secondary bacteremia) was more common than among patients with CA bacteremia (88% vs. 54%; x2 = 37.355; P < .001). The sites of primary foci are summarized in table 2.
Complicated vs. uncomplicated bacteremia. Among the whole study group, 176 patients (63%) had complicated bacteremia, as defined by the existence of a nonremovable initial focus. Significantly fewer patients with CA bacteremia had a removable focus than did patients with HA bacteremia (2.5% vs. 51%; x2 = 51.810; P < .001).
Clinical significance of bacteremia. Overall, 60% of the cases of bacteremia were clinically significant. In 4% no classification could be made. Sixty-eight percent of cases of HA bacteremia but only 46% of cases of CA bacteremia were clinically significant (x2 = 9.874; P < .002). Prognosis. The large proportion of patients with a poor prognosis (57%) points to the importance of the underlying condition as risk factor for S. aureus bacteremia. Patients with HA bacteremia had a poor prognosis more frequently than did patients with CA bacteremia (63.5% vs. 41%; x2 = 9.704; P = .002). Similarly, a good prognosis was more frequent among patients with CA bacteremia (15%) than among those with HA bacteremia (4%) (X2 = 5.8156; P = .016).
* Perforating ulcer of the foot and/or osteomyelitis (18), transvenous pacemaker (5), bronchitis (3), dental abscess (3), arteriovenous shunt infection (3), urinary tract infection (3), gluteal abscess (2), intraarticular injection (2), epidural catheter (1), vesical catheter (1), pleural catheter (I), acne conglobata ( ), intestinal infection (I), throat infection (1), and anterior
Therapy. Only 43% of all patients with bacteremia could be considered cured, and in 14% an improvement in their condition was noted. Sustained treatment failure or relapse was observed in 24% and 8% of the patients, respectively. In 11% of cases no clear statement about the efficacy of therapy could be made, either because antibiotics were withheld owing to an unfavorable prognosis in regard to underlying disease or because the patient was transferred to another hospital. A significantly higher percentage of patients with HA bacteremia were cured than were patients with CA bacteremia (47% vs. 31%; x2 = 4.728; P = .029). Initially over one-quarter of all patients with bacteremia received inappropriate antibiotic treatment. For uncomplicated cases of bacteremia, 17% of the initial treatments were inappropriate, as compared with 32% for complicated cases of bacteremia (X2 = 6.834; P = .009). Sixty-one patients with bacteremia underwent surgical removal of a primary or secondary focus.
Surgery was more frequently performed in patients with complicated bacteremia than in those with uncomplicated bacteremia (29% vs. 9.5%; x2 = 14.742; P < .001).
The median duration of antimicrobial therapy for 257 bacteremic patients was 15 days (range, 0-157 days). Seventy patients with CA bacteremia received antibiotics for a median of 22 days (mean, 30.7 days), and 187 patients with nosocomial infection were treated for a median of 12 days (mean, 16.2 days). A total of 104 patients with uncomplicated bacteremia were treated with use of an intravenous catheter for a median of 9.5 days (mean, 11.3 days; range, 0-60 days); two patients were cured by catheter removal without use of antibiotics.
At the time of the first blood culture positive for S. aureus, the treating physician judged 48 (19%) of 247 patients to be irrelevantly infected or the blood culture to be contaminated. For these patients no therapy was started, or an inappropriate initial treatment was not changed according to the susceptibility pattern of the isolate. After the introduction of an infectious disease service at the hospital in 1982, the number of misinterpreted blood cultures dropped from 12 to 4.8 per year.
Mortality rate. The overall mortality rate among patients with S. aureus bacteremia was 33.6%. In 20% of cases, death was directly related to S. aureus, and in 28%, to the underlying illness. In 52% of the patients, the cause was unclear or not due to the S. aureus infection alone. A comparison of the death rates associated with differently defined bacteremia demonstrated that uncomplicated bacteremia was associated with a lower mortality rate than was complicated bacteremia (24% vs. 40%; x2 = 6.829, P < .01). Similarly, secondary bacteremia was also associated with a lower mortality rate (30% vs. 45%, x2 = 4.183, P = .05). There was no significance in the differences between CA and HA bacteremia and between clinically significant and insignificant bacteremia in regard to mortality. The mortality rate was higher among patients with endocarditis (65%; n = 23) as compared with patients with secondary foci of infection who did not have endocarditis (49%, n = 57) (x2 = 4.5859; P = .03). The mortality rate among patients without any metastatic infections (n = 201) was 25%, a significantly lower rate than the 49% found among patients with secondary foci (X2 = 30.7272; P<.001).
Sensitivity pattern. During the investigated period, only one methicillin-resistant strain-which was also resistant to erythromycin, doxycycline, chloramphenicol, and trimethoprim-sulfamethoxazole-was isolated. HA bacteremia was less often followed by secondary foci and endocarditis but was associated with a mortality rate similar to that associated with CA bacteremia, a finding which was also observed in a newer prospective study [49] . The more benign course of HA bacteremia is well known from the literature [ 9, 48, 50, 51] . However, the mortality rate remains high, and additional factors such as underlying conditions [ 24, 36, 43], the age of the patients [10, 21, 23, 45] , and the nature of the primary infection appear to influence the outcome. Cases of uncomplicated bacteremia were significantly less often followed by secondary foci and were associated with a lower mortality rate than were complicated cases, but the two did not differ in terms of the associated incidence rate of endocarditis. A low risk of subsequent secondary foci after an episode of uncomplicated bacteremia was also reported in two prospective studies [52, 53] , whereas the low incidence of endocarditis in these and other investigations [9, 41] contrasted with the results of our study. Watanakunakorn and Baird [46] mentioned in their study the significant risk of developing endocarditis after an episode of uncomplicated bacteremia, whereas in a recent publication [40] the risk was called "small but definite."
Discussion
In our series, the mortality rate was highest among patients with no or nonremovable foci, a finding which may be explained by the delay in instituting effective treatment. The earlier awareness of the possibility of bacteremia in cases with obvious local staphylococcal lesions and, consequently, the institution of significantly more appropriate and earlier treatment may have prevented many sequelae. Michel et al. [17] showed a 4.4-fold higher mortality rate among patients with "clinically significant bacteremia," as defined in their Methods section. In contrast, in our series this classification was not discriminative in terms of the fatality rate. This may be because of the fact that before the introduction of an infectious disease service, a considerable proportion of patients with subtle symptoms received no or inadequate therapy in our hospital.
In conclusion, S. aureus bacteremia remains a major problem and is associated with a high rate of mortality. The presence of a source of bacteremia was the only factor predictive of the outcome. Patients for whom the source of bacteremia was defined had a better prognosis with regard to mortality rate, incidence of endocarditis, and secondary foci. Our data suggest that an improvement of the prognosis could be achieved by more competent interpretation of positive blood cultures yielding S. aureus and by earlier initiation ofantistaphylococcal therapy.
